CHEO researchers look at cancer in the lab and at the bed side. For instance, some of our scientists consider biology by analyzing tumor biopsies, and others determine which virus therapies can wipeout cancer cells. While our pediatric oncologists address treatment options by looking at what timing is optimal for administering chemotherapy; whether or not acupuncture helps to alleviate nausea; if natural supplements can help to stimulate appetite – the bottom line is to fight cancer for kids!
CHEO is a member of the Children’s Oncology Group (COG) which aims to understand the causes of cancer and find more effective treatments for children. As part of this international research network, our clinical pediatric cancer researchers have access to funding, treatments, research support and services specifically aimed at better outcomes for kids.
Many CHEO oncologists are pursuing research interests, independent of the COG network. Our diverse team of clinical investigators are collaborating on more than 30 multi-centre studies ranging in topics from evaluating the cardiac late effects in childhood cancer survivors; to looking at central line dysfunction in children with cancer; to applying biomarkers to long term effects of childhood/adolescent cancer treatment; and even equipping patients with iPhones to record their pain scale.
Furthermore, half of our esteemed senior scientists are looking at cancer from an altogether different standpoint – in the laboratory. We are leading world class experiments using protein synthesis, oncolytic virus therapies, and anti-IAP drugs with the goal of getting into clinical trials as soon as possible.
Oncology research is very broad, active portfolio at CHEO and we invite you to contact us to learn more.